Abstract Staphylococcus aureus is one of the most prevalent organisms responsible for nosocomial infections, and cases of community-acquired S.
Introduction
The Gram positive pathogen Staphylococcus aureus is responsible for a diverse range of disease pathologies, ranging from relatively minor dermal lesions to severe invasive sepsis disorders, pneumonia, and deep tissue abscess [1] [2] [3] . S. aureus is the causative agent of the majority of hospital-acquired bacterial infections throughout the developed world [4, 5] , and community-acquired methicillin-resistant S. aureus (CA-MRSA) is now the number one bacterial cause of death in the USA [6] . Contributing to the widespread pathogenesis of S. aureus is its presence as a persistent commensal microorganism in approximately 20% of the population, and intermittently in a further 60%; primarily in the anterior nares but also the axillae, groin, and gastrointestinal tract [7] . Because of its ubiquitous presence, a breach of host defenses can lead to invasive and potentially fatal S. aureus infection [3] .
Most clinical isolates of S. aureus possess an array of virulence factors which allow invasion and blood stream dissemination even in the absence of significant tissue trauma [8] . The incidence of S. aureus bacteremia has risen considerably since the emergence of CA-MRSA and the prevalence of S. aureus infection in the hospital environment [9] . Endocarditis, vertebral osteomyelitis, and deep tissue abscesses account for more than 50% of secondary S. aureus infections [10] . S. aureus is the organism most commonly associated with bacterial brain abscesses [11] . Brain abscesses are a complication that may arise following surgery, head injury, or from inadequately treated S. aureus sepsis or meningitis [11] . Although meningitis is considered a rare complication of S. aureus infection, there are an increasing number of clinical reports detailing meningitis resulting from S. aureus infection of an unknown source [12, 13] . In these cases, hematogenous spread of bacteria from a primary site of infection implies that S. aureus has the ability to cross the blood-brain barrier (BBB) to penetrate the central nervous system (CNS). While several other Gram positive pathogens, including Streptococcus agalactiae (group B Streptococcus, GBS) and Streptococcus pneumoniae (SPN), are well known for their ability to gain access to the CNS, staphylococcal BBB penetration has not been investigated.
The Gram positive cell wall is composed of a thick layer of peptidoglycan as well as lipid-linked teichoic acids, known as lipoteichoic acids (LTA). LTA is a glycerol phosphate polymer that extends through the peptidoglycan cell wall and is thought to be involved in host cell attachment by various pathogens [14, 15] . In staphylococci, streptococci, and bacilli, LTA is attached to the cytoplasmic membrane via a glycolipid anchor; specifically β-gentiobiosyldiacylglycerol (diglucosyl-diacylglycerol [DGlcDAG]) [16, 17] . YpfP is a glycosyltransferase required for DGlcDAG synthesis in both S. aureus and Bacillus subtilis [16] . Deletion of ypfP in S. aureus results in an 87% reduction in cellular-associated LTA [17] . In the present study we demonstrate for the first time the ability of S. aureus to directly invade and penetrate BBB endothelium. Resulting tissue damage, brain abscesses, and meningeal inflammation were visualized following infection in an in vivo model of hematogenous staphylococcal meningitis. Furthermore, a ΔypfP mutant strain exhibited a significant decrease in BBB penetration, indicating that LTA surface anchoring contributes to the development of S. aureus CNS disease arising from hematogenous dissemination.
Materials and methods
Bacterial strains and culture conditions S. aureus wild-type strains used were ISP479C [18] , SA113 [19] , USA 300 strain TCH1516 [20] , and MRSA strain ATCC 33591. The yfpP::ermB (ΔypfP) mutant was constructed by gene replacement of SA113 ypfP with ermB [17] . The ΔypfP(pRB473ypfP) complemented mutant strain (ΔypfP compl.) contains the ypfP gene and upstream promoter expressed on shuttle vector pRB473 [17] . All S. aureus strains were grown in Luria-Bertani (LB) medium or Tryptic Soy medium, and the ΔypfP mutant and complementation plasmid maintained in medium containing erythromycin (15 µg mL −1 ) and chloramphenicol (10 µg mL −1 ), respectively. S. agalactiae (group B Streptococcus) wild-type strain COHI [21] and its corresponding glycosyltransferase mutant, ΔiagA [22] , were grown in Todd-Hewitt Broth (THB) medium and THB supplemented with chloramphenicol (2 µg mL −1 ), respectively. S. pneumoniae wild-type strain D39 [23] and glycosyltransferase mutant ΔGTG were grown in THB supplemented with 0.5% yeast extract (THY) under microaerophilic conditions (37°C, 5% CO 2 ), the ΔGTG strain was maintained with erythromycin (2 µg mL −1 ).
Human BBB model and bacterial assays
The human brain microvascular endothelial cell line, hBMEC [24] , was obtained from Kwang Sik Kim (Johns Hopkins University, Baltimore, MD, USA). Cells were maintained in RPMI cell culture medium (Invitrogen) 10% fetal bovine serum, at 37°C with 5% CO 2 as described elsewhere [24, 25] . Human umbilical vein endothelial cells (HUVEC) were maintained in endothelial cell growth medium as per manufacturer's instructions (Lonza). S. aureus adherence and invasion assays were performed as described previously for other Gram positive meningeal pathogens [22, 26, 27] , with minor modifications as described in figure legend. Experiments involving cytochalasin D (Sigma), an actin polymerization inhibitor, were carried out as described previously [28] . Comparative hBMEC adherence and invasion assays were carried out with meningeal pathogens GBS (MOI of 1.0) and SPN (MOI of 10) as described previously [22, 27] .
Microscopy
To visualize cell-associated and invasive S. aureus, hBMEC were propagated on collagen-coated glass cover slips. S. aureus were added to confluent hBMEC monolayers at an MOI of 10 and incubated for 60 min. Monolayers were washed and heat-fixed prior to Gram staining and mounted using Cytoseal-60 (Thermo Scientific). Images were digitally captured using a Zeiss Axio inverted microscope equipped with a charge-coupled device camera. For transmission electron microscopy (TEM) hBMEC were propagated in Permanox plastic chamber slides (Thermo Scientific). S. aureus were added to confluent hBMEC monolayers as described above. Following incubation monolayers were washed and samples were preserved in one of two ways: (1) was carried out to determine significance for frequency of infection models. Significance was accepted at p<0.05.
Results and discussion
S. aureus adheres to and invades brain endothelium
All strains of S. aureus are capable of causing serious disease, and the recent rise in numbers of patients presenting with CA-MRSA infections has led to an increase in the overall number of deaths attributed to invasive and disseminated S. aureus infection. S. aureus meningitis, although less common than that caused by traditional Gram positive meningeal pathogens such as SPN and GBS, is associated with a mortality rate greater than 50% [12] . We used immortalized hBMEC, the endothelial cell layer which constitutes the BBB [24] , to examine the physical interaction of S. aureus with the human BBB. After a 60-min infection period, adherent staphylococci were visualized by microscopy ( Fig. 1a) . Subsequent analysis using TEM revealed bacteria in close proximity to cell surface microvillus projections and inside endocytic vacuoles (Fig. 1b, c) , confirming the ability of S. aureus to adhere to and invade brain endothelial cells. To quantify the number of adherent and invasive organisms, we optimized our previously established hBMEC assays [22] . All S. aureus strains examined exhibited the ability to attach to and invade hBMEC (Fig. 1d) .
The presence of intracellular staphylococci observed by EM analysis suggested that S. aureus may alter the host cytoskeleton to initiate its own uptake. To determine whether the observed S. aureus invasion required elements of the hBMEC cytoskeleton, we performed invasion assays using hBMEC monolayers preincubated with cytochalasin D, a potent actin microfilament aggregation inhibitor. As shown in Fig. 1e , the addition of cytochalasin D resulted in a marked decrease in S. aureus invasion compared to the dimethyl sulfoxide (DMSO)-treated control (p<0.001), suggesting that S. aureus modulates host cell cytoskeleton rearrangement during cellular invasion. When assessing S. aureus invasion relative to adherence of hBMEC, an average of 34% of total hBMEC-associated S. aureus had invaded the intracellular compartment within the incubation period. This relative rate of invasion is comparable to that reported for GBS (30%) [26] , and S. pneumoniae (7%) [29] .
S. aureus penetration of the BBB in vivo
Previous animal models of S. aureus CNS disease and brain abscess formation have relied on the introduction of bacteria directly to the brain via surgical implantation of coated beads [11, 30] , and do not allow investigation of direct BBB penetration. We therefore sought to corroborate our findings in vivo in a murine model of hematogenous meningitis. Mice were infected with S. aureus intravenously via tail vein injection and monitored for 96-h post- injection (p.i.). In this model, the number of bacteria recovered from the bloodstream decreased over time (Fig. 2a) while S. aureus penetrated the BBB and persisted in the brain (Fig. 2b) . Consistent with previous studies [31] , bacteria were recovered from the kidneys of all mice, with the bacterial load increasing throughout the course of the experiment (Fig. 2c) . Histopathology of brains from representative mice infected for 96 h with S. aureus displayed meningeal thickening and hemorrhage, leukocytic infiltration, and areas of micro-abscess formation in the brain parenchyma (Fig. 2d-f) . Clusters of S. aureus were observed at the center of the brain abscess (Fig. 2g) . Our results clearly show that not only does S. aureus penetrate the BBB, it persists in the brain for up to 4 days postinfection and is capable of causing clinical signs of meningitis and abscesses formation.
Lipoteichoic acid cell wall anchoring contributes to S. aureus BBB penetration Deletion of the GBS glycosyltransferase, iagA, resulting in defective LTA surface anchoring, was shown to affect the ability of GBS to invade hBMEC and penetrate the BBB in vivo [22] . Although not homologous, the functional similarities between GBS iagA and the S. aureus ypfPencoded glycosyltransferase led us to hypothesize that LTA Fig. 3 Contribution of membrane-anchored LTA to S. aureus BBB penetration. a Relative hBMEC adherence and invasion by S. aureus SA113, isogenic mutant strain ΔypfP and complemented mutant strain ΔypfP compl. (MOI=0.1). b Invasion of hBMEC by parental S. aureus SA113 (MOI=0.1), group B Streptococcus (GBS; MOI=1.0) and Streptococcus pneumoniae (SPN; MOI=10) and their respective glycosyltransferase mutants ΔypfP, Δiag, and ΔGTG. All experiments were repeated at least three times in triplicate; data from a representative experiment are shown. *p<0.05, **p<0.01. S. aureus SA113 and ΔypfP CFU recovered from blood (c) and brain (d) tissue of CD-1 male mice 72-h post-i.v. infection (∼3×10 6 cfu). e Analysis of bacterial counts recovered from the brain 96-h post-i.v. injection with equal amounts of WT and ΔypfP mutant S. aureus SA113 strains (1×10 7 total cfu). CFU were enumerated on LB plates or on LB supplemented with erythromycin to distinguish between WT and mutant bacteria. An overall ratio of 1 indicates equal numbers of WT and ΔypfP CFU, a ratio greater than 1 indicates a higher number of WT bacteria were recovered. f-h Histopathology of H&E-stained brain tissue from representative mice infected with SA113 or ΔypfP in (d). f Hemorrhage and meningeal thickening observed in a WTinfected mouse with a high recovered CFU. g Normal brain architecture was observed in a mouse infected with the ΔypfP mutant with little or no recovered CFU. h Meningeal thickening was evident in a ΔypfP-infected mouse with a high recovered CFU membrane anchoring may also play a role in S. aureus interaction with BBB endothelium. S. aureus strain SA113 and isogenic ΔypfP mutant [17] were used to investigate the role of LTA surface anchoring in S. aureus BBB penetration. Adherence and invasion assays using our in vitro hBMEC model showed that the ΔypfP mutant strain maintained hBMEC adherence capability but exhibited a significant decrease in hBMEC invasion compared to the wild-type strain (p<0.01; Fig. 3a) . Similar results were obtained in another endothelial, HUVEC, cell line (Supplemental Fig. 1) . Complementation of the mutation with the ypfP gene restored invasion to WT levels (Fig. 3a) . In SPN, glycosyltransferase homologues responsible for synthesis of diglycosyldiacylglycerols have been described [32, 33] but have not been studied in the context of bacterial invasion of host cell barriers. We examined hBMEC invasion of an SPN mutant, ΔGTG, lacking a glycosyltransferase required for MGlcDAG synthesis (a precursor to DGlcDAG) and observed a similar reduction in invasive capability comparable to S. aureus ΔypfP and GBS ΔiagA (Fig. 3b) . These results suggest that the role of LTA surface anchoring in brain endothelial cell invasion is conserved among other meningeal pathogens, and may extend to other endothelial cell types.
We hypothesized that the decreased invasion by the S. aureus ΔypfP mutant would translate into a diminished ability to penetrate the BBB and produce meningitis in vivo. We therefore infected groups of mice with the WT strain or the isogenic ΔypfP mutant. Seventy-two hours post-infection the levels of S. aureus detected in the blood of each group were essentially identical (Fig. 3c) . However, significantly fewer animals infected with the ΔypfP mutant had bacteria in the brain compared to animals infected with the WT strain (Fig. 3d) . Interestingly, there was no difference in the ability of the ΔypfP mutant to enter the kidney (Supplemental Fig. 2 ). To further assess the contribution of YpfP to S. aureus BBB penetration and bacterial fitness, we performed a more sensitive in vivo competition assay. Mice were challenged with equal amounts of WT S. aureus and the ΔypfP mutant. At the experimental end point (96 h), brains were collected for the enumeration of surviving bacteria. Significantly more WT than ΔypfP mutant bacteria were recovered from the brain, p<0.001, as demonstrated by a WT-mutant ratio >1 in 10 out of 12 animals (Fig. 3e) . This finding demonstrates a crucial role for ypfP in bacterial fitness and further corroborates the contribution of anchored LTA to S. aureus CNS disease. Histopathology of brains from representative WT or mutant-infected animals in Fig. 3d revealed characteristic meningeal inflammation and hemorrhage in animals with a high bacterial load, regardless of the presence of anchored LTA, and normal brain architecture in animals infected with the ypfP mutant with little or no recovered CFU (Fig. 3f-h ). While our studies suggest that LTA significantly impacts BBB penetration, likely other staphylococcal factors also contribute to CNS invasion, as bacterial CFU were recovered from the brains of 50% of mice infected with the ΔypfP mutant. Additionally, our data demonstrate that LTA anchoring contributed to bacterial invasion of multiple endothelial cell lines but not to penetration of the kidney in vivo, indicating that ypfPmediated invasion applies to some but not all endothelial barriers.
Using electron microscopy and an established in vitro model of the BBB, we demonstrate here for the first time that S. aureus is capable of invading hBMEC, the singlecell layer that comprises the BBB. These results were corroborated in vivo in a model of hematogenous staphylococcal meningitis and CNS infection, whereby S. aureus penetrated the BBB within 24 h of initial infection, and persisted in the brain despite clearance from the bloodstream. Our results further suggest an important role for staphylococcal LTA in BBB penetration and CNS disease. While S. aureus BBB invasion requires further investigation, the results presented here represent an important development in our understanding of the ability of this formidable pathogen to penetrate the CNS. Furthermore, therapies directed at disrupting the LTA-glycolipid linkage may also be a novel approach for the prevention of CNS infection by S. aureus and other meningeal pathogens.
